# Inflammation-Induced CNS Glutamate During Breast Cancer Treatment

> **NCT02421978** · — · COMPLETED · sponsor: **Emory University** · enrollment: 98 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02421978
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-05-29
- **Final completion:** 2018-05-29
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2019-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02421978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02421978, "Inflammation-Induced CNS Glutamate During Breast Cancer Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02421978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*